|
Real-time Estimate
Cboe Europe
11:20:00 2026-09-10 EDT
|
5-day change | 1st Jan Change | ||
| 345.75 CHF | +6.75% |
|
0.00% | +5.38% |
| 09-03 | Hutchmed Enters Licensing Agreement With GSK for Cancer Drug | DJ |
| 09-02 | Roche, Treeline Biosciences to Evaluate Combination Therapy for B-cell Lymphomas | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1,002B | |||||
| 644B | - | ||||
| 443B | |||||
| 343B | |||||
| 262B |
Select your edition
All financial news and data tailored to specific country editions
